Curewiki Company Profile

Background

Overview

Curewiki is a Brussels-based startup founded in 2022, dedicated to enhancing patient access to clinical trials through an AI-driven platform. The company aims to streamline the recruitment process by connecting patients with suitable clinical studies, thereby accelerating medical research and treatment development.

Mission and Vision

Curewiki's mission is to empower patients by providing equal opportunities to participate in clinical trials, fostering a more inclusive and efficient research environment. The vision is to become a leading platform in Europe, facilitating access to medical treatments of tomorrow for a diverse patient population.

Primary Area of Focus

The company focuses on bridging the gap between patients and clinical trials, utilizing advanced technologies to match patient profiles with appropriate studies. This approach aims to reduce recruitment delays and enhance the overall efficiency of clinical research.

Industry Significance

By addressing the challenges in clinical trial recruitment, Curewiki plays a pivotal role in accelerating medical innovation and improving patient outcomes. Its platform contributes to the advancement of healthcare by facilitating timely access to new treatments and therapies.

Key Strategic Focus

Core Objectives

Patient Empowerment: Enable patients to actively participate in clinical trials, providing them with the tools and information needed to make informed decisions.

Efficiency Enhancement: Streamline the recruitment process for researchers, reducing screening times and costs associated with participant enrollment.

Market Expansion: Broaden the platform's reach across Europe, aiming to list all European studies by 2025 and achieve profitability by 2026.

Specific Areas of Specialization

AI-Driven Matching: Utilize artificial intelligence to analyze patient data and match individuals with suitable clinical trials based on inclusion and exclusion criteria.

Comprehensive Database: Maintain an extensive database of clinical trials, including over 14,000 studies across approximately 170,000 sites, representing 60% of studies currently recruiting in Europe.

Key Technologies Utilized

Artificial Intelligence: Employ AI algorithms to process complex medical data, facilitating accurate and efficient patient-trial matching.

Data Analytics: Analyze large datasets to identify patterns and insights, improving the precision of trial recommendations.

Primary Markets Targeted

Patients: Individuals seeking access to innovative treatments and those interested in contributing to medical research.

Researchers and Clinical Trial Managers: Organizations and professionals aiming to enhance participant recruitment and streamline the clinical trial process.

Financials and Funding

Funding History

Curewiki has secured early-stage venture capital funding, with a total raised amount between €500K and €1 million.

Recent Funding Rounds

The company has completed an early-stage VC funding round, details of which are not publicly disclosed.

Notable Investors

Invest.BW is a known investor in Curewiki.

Intended Utilization of Capital

The raised capital is intended to support the expansion of Curewiki's platform, enhance technological capabilities, and facilitate market penetration across Europe.

Pipeline Development

Key Pipeline Candidates

Curewiki's platform encompasses a wide range of clinical trials across various therapeutic areas, including oncology, cardiology, and neurology. The company continually updates its database to include new studies, ensuring comprehensive coverage of available trials.

Stages of Clinical Trials or Product Development

Curewiki's platform is in the operational stage, actively connecting patients with ongoing clinical trials. The company is also in the process of expanding its database to include all European studies by 2025.

Target Conditions

The platform covers a broad spectrum of conditions, including both common and rare diseases, aiming to provide access to clinical trials for a diverse patient population.

Relevant Timelines for Anticipated Milestones

2025: Aim to list all European studies on the platform.

2026: Target profitability.

Technological Platform and Innovation

Proprietary Technologies

AI-Powered Matching System: A proprietary system that analyzes patient profiles and matches them with suitable clinical trials based on complex inclusion and exclusion criteria.

Significant Scientific Methods

AI Algorithms: Utilize advanced machine learning algorithms to process and interpret medical data, enhancing the accuracy of patient-trial matching.

Data Analytics: Employ data analytics to identify patterns and insights, improving the precision of trial recommendations.

AI-Driven Capabilities

Natural Language Processing (NLP): Use NLP to interpret complex medical texts within clinical trials, accurately identifying eligibility criteria for patient participation.

Leadership Team

Executive Profiles

Jean-Sébastien Gosuin: Co-Founder and CEO. A serial entrepreneur and childhood cancer survivor, Jean-Sébastien leads Curewiki with a focus on patient-centric innovation.

Koen Blanquart: Chief Technology Officer. Oversees the technological development of Curewiki's platform, ensuring the integration of advanced technologies.

Edwin Klumper, Ph.D.: Chief Business Development Officer & Business Development Lead. Manages commercial relations and strategic partnerships to drive growth.

Raphaël Robiano: Chief Product Officer. Leads product strategy, focusing on user experience and data-driven growth.

Leadership Changes

No significant leadership changes have been reported recently.

Market Overview and Competitor Profile

Market Insights and Dynamics

The clinical trial recruitment market is evolving towards patient-centric models, with increasing emphasis on efficiency and inclusivity. Curewiki's approach aligns with these trends, positioning it as a key player in the European market.

Competitor Analysis

Studykik: A competitor in the clinical trial recruitment space, focusing on connecting patients with relevant studies.

FindMeCure: Offers a platform for patients to find and join clinical trials, aiming to simplify the recruitment process.

Paradigm Clinical Research Centers: Provides clinical trial services, including patient recruitment and management.

Strategic Collaborations and Partnerships

Curewiki collaborates with research sites, pharmaceutical companies, and healthcare providers to optimize recruitment pipelines and ensure equitable access to clinical trials.

Operational Insights

Curewiki's platform offers a user-friendly interface for patients to register, build dynamic profiles, and apply for trials, empowering individuals to take control of their participation.

Strategic Opportunities and Future Directions

Curewiki aims to expand its platform to include all European studies by 2025, enhancing its market presence and impact on clinical trial recruitment.